KPV

What It Is

A tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). KPV retains the anti-inflammatory signaling properties of the full alpha-MSH molecule while consisting of only three amino acids.

How It Works

KPV enters the cellular environment

→

Inhibits NF-kB nuclear translocation

→

Pro-inflammatory cytokine production is reduced

→

Inflammatory signaling cascades are modulated

What Researchers Study It For

NF-kB pathway inhibition and immune modulation

Inflammatory cytokine regulation

Gut barrier function and mucosal tissue models

Skin inflammation and dermatological research

Common Research Protocols

KPV is supplied as a lyophilized powder and reconstituted with bacteriostatic water. In preclinical studies, it is administered via subcutaneous injection. Its small size (three amino acids) contributes to favorable stability and bioavailability characteristics in research settings.

Community Interest Areas

KPV has drawn research interest for its targeted anti-inflammatory mechanism via NF-kB pathway inhibition. Unlike broad-spectrum anti-inflammatory agents, KPV modulates specific inflammatory cascades derived from the alpha-MSH signaling pathway. Researchers explore it in gut inflammation models, skin biology, and immune modulation studies. It is a key component in the Klow formulation alongside BPC-157, TB-500, and GHK-Cu.

3 Amino Acids Tripeptide derived from alpha-MSH C-terminal sequence

Peer-Reviewed Studied for NF-kB inhibition and inflammatory cytokine modulation

For research purposes only. Not intended for consumption, clinical application, or diagnostic use.

What It Is

How It Works

What Researchers Study It For

Common Research Protocols

Community Interest Areas

What Are Peptides?

Are Peptides Safe?